IDEAYA Biosciences (IDYA) Operating Income Growth (3y) (2021 - 2026)
IDEAYA Biosciences (IDYA) Operating Income Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,042.03 Bn | 67,041.74 Bn | - | 16.96% |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.62 Bn | 466.83 Bn | 1.35 Bn | 38.78% |
| 5 | Vertex Pharmaceuticals | 121.97 Bn | 114.72 Bn | 2.59 Bn | 13.47% |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn | -12.10% |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | - |
| 8 | Argenx Se | 55.75 Bn | 50.57 Bn | 1.41 Bn | 69.02% |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | 55.96% |
| 10 | IDEAYA Biosciences | 3.22 Bn | 2.55 Bn | - | -60.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -60.45% |
| Dec 31, 2025 | -52.93% |
| Sep 30, 2025 | 447.73% |
| Jun 30, 2025 | -58.04% |
| Mar 31, 2025 | -81.05% |
| Dec 31, 2024 | -98.72% |
| Sep 30, 2024 | -78.75% |
| Jun 30, 2024 | -80.44% |
| Mar 31, 2024 | -77.42% |
| Dec 31, 2023 | -99.49% |
| Sep 30, 2023 | -88.62% |
| Jun 30, 2023 | -37.47% |
| Mar 31, 2023 | -28.18% |
| Dec 31, 2022 | -32.69% |
| Sep 30, 2022 | 27.17% |
| Jun 30, 2022 | -26.05% |
| Mar 31, 2022 | -12.10% |
| Dec 31, 2021 | -26.23% |
| Sep 30, 2021 | 4.92% |
| Jun 30, 2021 | -13.44% |